Hide Board Information

Show Board Information

UOMO Media, Inc. UOMO

Board Mod: Add me as mod

Asst Mods:

Last Post: 01/30/2020 4:23:52 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 1

UOMO Media, Inc. (OTCMRKTS: UOMO) Stock Message Board

1. UOMO Company Profile

    

2. UOMO Time & Sales

    

3. UOMO Recent News

    

4. UOMO Filings

    

5. UOMO Financials

    

6. UOMO Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

9	UOMO 26% v363K c1.47 H1.47	znewcar1	01/30/2020 4:23:52 PM
8	UOMO .0012 Volume alert	lowman	10/30/2017 10:03:12 AM
7	$UOMO Huge Alert on social media	jmtimz	05/21/2015 9:49:58 AM
6	UOMO Financials 07/16/2014 11:14:49 UOMO Media,	Emylers	07/16/2014 12:14:45 PM
5	Latest Uomo Media Inc (UOMO) Headlines UOMO Media	Stock_Tracker	03/11/2014 11:36:25 PM
4	UOMO 0.013 Stock Charts $UOMO 1 Month Chart	chartguy89	03/10/2014 11:40:39 AM
3	UOMO Stock Charts Last: +0.0049 Sunday, March 2,	chartguy89	03/02/2014 5:15:13 AM
2	UOMO UOMO Media Inc. Research DD Guide	Rosner	04/26/2013 10:48:38 PM
1	UOMO Launches UOMO Filmworks	Jerseyfish	04/24/2013 7:45:16 AM

Recent Articles

• Copper Property CTL Trust Monthly Update for November 2025
• Elon Musk's Inspiring Advice for Aspiring Innovators
• Investigation of Major Mergers: A Look into Four Corporations
• How Chad IDE is Transforming Developer Productivity Today
• BexBack Unveils Exciting $100 Welcome Bonus for Traders
• Ray Dalio's Humble Beginnings: A Lesson in Resilience
• Lundbeck's Bexicaserin Shows Promise in Managing Childhood Epilepsies
• Lundbeck Unveils Positive Findings on Bexicaserin for Unique Epilepsies
• RadiantVibe Capital Unveils Insight Access Dashboard Initiative
• Kevin O'Leary's Formula for Financial Success: The $5M Rule
• Educators Unite for a Brighter Future at the Yidan Summit
• Elon Musk's Response to EU's $140 Million Penalty on X
• Copper Market Perspectives: Bullish Trends Amidst Contrasting Views
• Prelude Therapeutics Unveils Innovative MPN Treatment Breakthrough
• Current Trends in Cryptocurrency Markets: BTC, DOGE, ETH Updates
• Former MrBeast Creator Launches AI Platform for Content
• LiberNovo Launches Revolutionary Ergonomic Chair Globally
• LiberNovo Launches Omni Ergonomic Chair in European Market
• Blokees Unveils Exciting New Products at Major Comic Event
• Jensen Huang Reflects on Partnership with Elon Musk and Tesla
• Significant Progress in CLL Treatment with Lisaftoclax Insights
• New Findings on Lisaftoclax at ASH Annual Meeting 2025
• Marjorie Taylor Greene Opens Up About Trump and Political Rift
• Opportunity for Sprouts Farmers Market Investors Amid Legal Actions
• Labor Management Systems: A Pathway to Workforce Optimization
• Dave Ramsey Encourages Workers to Seek Fulfillment Elsewhere
• Perrigo Company Faces Class Action: Key Details for Investors
• Breakthrough CAR-T Therapy Shows Promise in Non-Hodgkin's Lymphoma
• CARVYKTI® Shows Promising Long-Term Remission Rates in Myeloma
• Exploring the Upcoming Boom in In-Memory Database Solutions
• System Infrastructure Software Market Expected to Surge by 2032
• Genmab's Epcoritamab Shows Promising Results in Trials
• Nurix Therapeutics Advances Bexobrutideg for CLL Patients
• Cogent Biosciences Unveils SUMMIT Study Insights on Bezuclastinib
• Class Action Lawsuit Filed Against Blue Owl Capital: Key Info
• Promising Phase 1 Results of Bexobrutideg for CLL Patients
• Cogent Biosciences Shares SUMMIT Trial Outcomes on Bezuclastinib
• Top 5 Trending Stocks: Insights on META, NFLX, and More
• CARVYKTI® Shows Promise in Long-Term Remission of Myeloma
• Concerns Rise Over ALT5 Sigma's Financial Stability and Audit Issues
• Education Leaders Unite for Change at Yidan Prize Summit 2025
• Projected Growth of Peptide Therapeutics Market by 2032
• Marex Stockholder Alert: Important Legal Deadline Approaching
• Comparative Analysis of MP Materials and USA Rare Earth Investment Prospects
• Viatris Sells Equity Stake in Biocon Biologics for $815 Million
• Important Information for StubHub Holdings, Inc. Investors
• Navigating 2026: JP Morgan's Insights on Economic Growth
• Deadline Approaches for aTyr Pharma Shareholders: Know Your Rights
• CBD Nutraceuticals Market Grows Rapidly, Expected to Hit $39B
• Transforming Hematology: clonoSEQ® Insights Fuel Progress